Vygon Group, an Écouen, France-based specialist single-use medical devices group, acquired Pilot, an Italian company which specializes in ECG guidance devices.
The financial terms of the deal have not been disclosed.
With the deal, the company is to acquire the ECG location and navigation technology of the Pilot TLS product, already marketed by Vygon, which enables precise positioning of the distal tip of central venous catheters, including in patients living with atrial fibrillation.
As a result, Vygon will be able to offer its international customers a comprehensive range of intravascular therapies: implantable ports, PICC lines, midlines and central venous catheters, as well as equipment (Vysion XS ultrasound system and ECG Pilot TLS system) to ensure their safe implantation.
Pilot TLS manufacturing and its future development will be handled within the Vygon group at its production and development site in Medwin, near Montpelier, France, which specializes in active medical devices.
Founded in 1962 and led by Stéphane Regnault, CEO, Vygon designs, manufactures and markets high-tech single-use medical devices for healthcare professionals in hospital and for private and independent practitioners.
Organized in five business units (Intensive Care – Neonatology, Enteral & Obstetrics – Intravascular Therapies – Cardiovascular & Surgery – Anesthesia & Emergency), Vygon combines local and international in-depth expertise and know-how in each individual field.
The company distributes over 205 million products a year in more than 120 countries through its network of 26 subsidiaries and 331 distributors.
Vygon products display the CE and/or FDA mark and are manufactured in the group’s eight factories in Europe, the USA and Colombia.
It is a mid-sized business employing 2,350 staff worldwide. The turnover in 2018 was €323 million ($365M), with 81% of this derived from Vygon’s international business.